HALDA THERAPEUTICS
Live / Registered — Registered (as of 10 Jan 2023)
What this means for you
Registered since 10 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88625022
- Registration number
- 6950371
- Mark type
- Stylized text
- Filed
- 20 Sept 2019
- Published for opposition
- 31 Mar 2020
- Registered
- 10 Jan 2023
- Attorney of record
- Glenn M. Cunningham
Goods and services
- Class 042 — Scientific and technological services: Biochemical research and development; Medical research; Pharmaceutical research and development; Research and development in the field of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of pharmaceuticals, medicine, and disease treatment
Owner
- Halda Therapeutics OpCo, Inc., New Haven, CT, US
- Halda Therapeutics OpCo, Inc., New Haven, CT, US
- Halda Therapeutics OpCo, Inc., Branford, CT, US
Prosecution history
- 10 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Dec 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Nov 2022 — USE AMENDMENT FILED
- 22 Nov 2022 — SOU EXTENSION 5 GRANTED
- 10 Nov 2022 — SOU EXTENSION 5 FILED
- 22 Nov 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2022 — TEAS STATEMENT OF USE RECEIVED
- 12 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2022 — SOU EXTENSION 4 GRANTED
- 10 May 2022 — SOU EXTENSION 4 FILED